BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
227 results:

  • 1. Exploring fetal brain tumor glioblastoma symptom verification with self organizing maps and vulnerability data analysis.
    Natarajan SK; S J; Mathivanan SK; Rajadurai H; M B BAM; Shah MA
    Sci Rep; 2024 Apr; 14(1):8738. PubMed ID: 38627421
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrating cine EPID, dynamic delivery, and the off-axis Winston-Lutz test to enhance quality control in multiple brain metastasis stereotactic radiotherapy.
    Retif P; Djibo Sidikou A; Waltener A; Letellier R; Al Salah A; Pfletschinger E; Taesch F; Verrecchia-Ramos E; Michel X
    Phys Med; 2024 Apr; 120():103343. PubMed ID: 38547546
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detection of HER2 expression using
    Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
    Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases.
    Berthet C; Lucia F; Bourbonne V; Schick U; Lecouillard I; Le Deroff C; Barateau A; de Crevoisier R; Castelli J
    Br J Radiol; 2024 Mar; 97(1156):820-827. PubMed ID: 38377402
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [
    Chen Q; Wang K; Ren X; Zhao X; Chen Q; Fan D; Zhang S; Li X; Ai L
    J Neurooncol; 2023 Dec; 165(3):547-559. PubMed ID: 38095773
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
    Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy in hippocampal avoidance whole-brain radiotherapy.
    Zhang HW; Hu B; Pang HW
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14218. PubMed ID: 38013656
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 68 Ga-PSMA-11 PET/CT Imaging in brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
    Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
    Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
    Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
    Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of passive-scattered and intensity-modulated proton beam therapy of craniospinal irradiation with proton beams for pediatric and young adult patients with brain tumors.
    Fukumitsu N; Kubota H; Demizu Y; Suzuki T; Hasegawa D; Kosaka Y; Kawamura A; Soejima T
    Jpn J Radiol; 2024 Feb; 42(2):182-189. PubMed ID: 37874526
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Development and validation of a radiomics-based prediction pipeline for the response to stereotactic radiosurgery therapy in brain metastases.
    Du P; Liu X; Xiang R; Lv K; Chen H; Liu W; Cao A; Chen L; Wang X; Yu T; Ding J; Li W; Li J; Li Y; Yu Z; Zhu L; Liu J; Geng D
    Eur Radiol; 2023 Dec; 33(12):8925-8935. PubMed ID: 37505244
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel Gateaux derivatives with efficient DCNN-Resunet method for segmenting multi-class brain tumor.
    Murmu A; Kumar P
    Med Biol Eng Comput; 2023 Aug; 61(8):2115-2138. PubMed ID: 37338739
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Synthetic CTs for MRI-only brain RT treatment: integration of immobilization systems.
    Masitho S; Grigo J; Brandt T; Lambrecht U; Szkitsak J; Weiss A; Fietkau R; Putz F; Bert C
    Strahlenther Onkol; 2023 Aug; 199(8):739-748. PubMed ID: 37285037
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
    Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
    J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Attention-guided multi-scale context aggregation network for multi-modal brain glioma segmentation.
    Wu S; Cao Y; Li X; Liu Q; Ye Y; Liu X; Zeng L; Tian M
    Med Phys; 2023 Dec; 50(12):7629-7640. PubMed ID: 37151131
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.
    Yang X; Hu C; Xing Z; Lin Y; Su Y; Wang X; Cao D
    Eur Radiol; 2023 Oct; 33(10):7003-7014. PubMed ID: 37133522
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Investigate the Possibility of Using Phosphorescence in Clinical Oncology as an Early Prognostic Test in Detecting brain Carcinogenesis.
    Vinnyk YO; Kryvoruchko IA; Boyko VV; Ivanova YV; Gramatiuk S; Sargsyan K
    J Fluoresc; 2023 Nov; 33(6):2441-2449. PubMed ID: 37103675
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Helical tomotherapy and two types of volumetric modulated arc therapy: dosimetric and clinical comparison for several cancer sites.
    Gallio E; Sardo A; Badellino S; Mantovani C; Levis M; Fiandra C; Guarneri A; Arcadipane F; Richetto V; Ricardi U; Giglioli FR
    Radiol Phys Technol; 2023 Jun; 16(2):272-283. PubMed ID: 37084071
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prospective Evaluation of Response to treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-brain Metastasis Treated with Only SRS.
    Dutta D; Reddy SK; Kamath RK; Sreenija Y; Nair H; Sashidharan A; Remesan Nair RA; Pushpuja KU; Kannan R; Edappattu A; Haridas NK; Jose WM; Keechilat P
    Neurol India; 2023; 71(1):62-71. PubMed ID: 36861576
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.